Copyright
©The Author(s) 2023.
World J Gastroenterol. Oct 21, 2023; 29(39): 5452-5470
Published online Oct 21, 2023. doi: 10.3748/wjg.v29.i39.5452
Published online Oct 21, 2023. doi: 10.3748/wjg.v29.i39.5452
Table 2 Spearman analysis of the correlation between prostaglandin F2α synthase expression level with clinicopathological, n (%)
Variables | No. of patients | PGFS expression level Spearman correlation | P value |
T stage | 0.666 | 0a | |
T1 or T2 | 25 (68) | ||
T3 or T4 | 12 (32) | ||
AJCC stage | 0.113 | 0.504 | |
I or II | 29 (78) | ||
III or IV | 8 (22) |
- Citation: Wang YJ, Xie XL, Liu HQ, Tian H, Jiang XY, Zhang JN, Chen SX, Liu T, Wang SL, Zhou X, Jin XX, Liu SM, Jiang HQ. Prostaglandin F2α synthase promotes oxaliplatin resistance in colorectal cancer through prostaglandin F2α-dependent and F2α-independent mechanism. World J Gastroenterol 2023; 29(39): 5452-5470
- URL: https://www.wjgnet.com/1007-9327/full/v29/i39/5452.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i39.5452